DCAT Week, the annual conference of The Drug, Chemical & Allied Trades Association, was successfully held in New York, USA, from March 20-23, 2023. DCAT Week is the premier business development event for companies in the pharmaceutical R&D and manufacturing and related industry sectors, bringing together many of the world's leading pharmaceutical companies and related professionals. More than 700 member companies from over 50 countries participated in this event, including global biopharmaceuticals and the upstream and downstream industry chains. Laviana Pharma once again attended this event as a member company.
DCAT Week is the premier global event held annually in New York City for companies in the bio/pharmaceutical manufacturing value chain. It is hosted by The Drug, Chemical & Allied Trades Association (Dcat), a not-for-profit, member-supported global business development association with a unique membership model that integrates innovator and generic drug manufacturers with ingredient suppliers, development and manufacturing services and related technologies.
At the event, Laviana Pharma fully demonstrated its platform advantages and one-stop solutions in the field of small molecule innovative drugs to representatives from global pharmaceutical companies and had in-depth exchanges with them. In addition, Laviana Pharma also introduced its newly completed GMP production base in Cangzhou and the upcoming New Drug & API Production and R&D Industrial Park, demonstrating Laviana Pharma's foresight and innovation in the field of CDMO R&D and production.
In the future, as the field of pharmaceutical innovation embraces more opportunities and challenges, Laviana Pharma will uphold the corporate mission of "changing the world with art of chemistry", actively explore and extend downstream of the industry value chain, strive to become a flagship CDMO company, and provide more one-stop comprehensive services for domestic and foreign innovative pharmaceutical companies, accelerating global pharmaceutical innovation.